指南与共识临床试验与 GCP医学人工智能与信息学

SPIRIT-AI 扩展:涉及人工智能干预的临床试验方案报告指南

Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.
指南 / 共识 · Nat Med · 2020-09-09

SPIRIT-AI 扩展是针对评估含人工智能(AI)成分干预的临床试验方案的新报告指南,与 CONSORT-AI 平行开发。其通过文献综述、专家咨询产生 26 个候选条目,经国际多利益相关方两阶段德尔菲调查(103 名利益相关方)、共识会议(31 名利益相关方)及清单试点(34 名参与者)确定。最终在 SPIRIT 2013 核心条目外新增 15 个条目,要求清晰描述 AI 干预、使用说明与技能、整合场景、输入输出数据处理、人机交互及错误案例分析。

要点

  • SPIRIT-AI 新增 15 个条目,应连同 SPIRIT 2013 核心条目一起报告。
  • 需清晰描述 AI 干预、使用说明与所需技能、整合场景及输入输出数据处理。
  • 需报告人机交互设计及错误案例分析,以助评估设计偏倚风险。

核心结论

  • SPIRIT-AI 扩展有助于促进 AI 干预临床试验方案的透明性和完整性,帮助理解、解读和批判性评价计划中的临床试验设计与偏倚风险。

研究设计与样本

  • 该指南通过分阶段共识过程制定,包括文献综述和专家咨询产生 26 个候选条目,经国际多利益相关方两阶段德尔菲调查(103 名利益相关方)、共识会议(31 名利益相关方)及清单试点(34 名参与者)最终确定。

主要发现

  • SPIRIT-AI 扩展包含 15 个新增条目,这些条目被认为对 AI 干预的临床试验方案足够重要。
  • 新增条目应连同 SPIRIT 2013 核心条目一起常规报告。

关键数值与推荐

  • SPIRIT-AI 建议研究者清晰描述 AI 干预,包括使用说明和所需技能。
  • 建议描述 AI 干预将被整合的场景。
  • 建议考虑输入和输出数据的处理。
  • 建议报告人机交互及错误案例分析。

临床怎么用

  • 研究者在撰写 AI 干预临床试验方案时,应在 SPIRIT 2013 核心条目基础上常规报告 SPIRIT-AI 的 15 个新增条目。
  • 使用 SPIRIT-AI 可帮助编辑、同行评审和读者理解、解读和批判性评价计划中的临床试验设计与偏倚风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The SPIRIT 2013 statement aims to improve the completeness of clinical trial protocol reporting by providing evidence-based recommendations for the minimum set of items to be addressed. This guidance has been instrumental in promoting transparent evaluation of new interventions. More recently, there has been a growing recognition that interventions involving artificial intelligence (AI) need to undergo rigorous, prospective evaluation to demonstrate their impact on health outcomes. The SPIRIT-AI (Standard Protocol Items: Recommendations for Interventional Trials-Artificial Intelligence) extension is a new reporting guideline for clinical trial protocols evaluating interventions with an AI component. It was developed in parallel with its companion statement for trial reports: CONSORT-AI (Consolidated Standards of Reporting Trials-Artificial Intelligence). Both guidelines were developed through a staged consensus process involving literature review and expert consultation to generate 26 candidate items, which were consulted upon by an international multi-stakeholder group in a two-stage Delphi survey (103 stakeholders), agreed upon in a consensus meeting (31 stakeholders) and refined through a checklist pilot (34 participants). The SPIRIT-AI extension includes 15 new items that were considered sufficiently important for clinical trial protocols of AI interventions. These new items should be routinely reported in addition to the core SPIRIT 2013 items. SPIRIT-AI recommends that investigators provide clear descriptions of the AI intervention, including instructions and skills required for use, the setting in which the AI intervention will be integrated, considerations for the handling of input and output data, the human-AI interaction and analysis of error cases. SPIRIT-AI will help promote transparency and completeness for clinical trial protocols for AI interventions. Its use will assist editors and peer reviewers, as well as the general readership, to understand, interpret and critically appraise the design and risk of bias for a planned clinical trial.

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Cruz Rivera S, Liu X, Chan AW, et al. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension. Nat Med. 2020. PMID: 32908284. doi:10.1038/s41591-020-1037-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。